Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022

BUY
$115.11 - $142.29 $96,001 - $118,669
834 New
834 $101,000
Q3 2021

Oct 13, 2021

SELL
$147.58 - $179.28 $1.24 Million - $1.51 Million
-8,421 Closed
0 $0
Q2 2021

Jul 16, 2021

SELL
$127.69 - $148.81 $55,928 - $65,178
-438 Reduced 4.94%
8,421 $1.25 Million
Q1 2021

Apr 20, 2021

BUY
$114.99 - $130.12 $1.02 Million - $1.15 Million
8,859 New
8,859 $1.13 Million
Q3 2020

Oct 20, 2020

SELL
$88.11 - $103.42 $181,330 - $212,838
-2,058 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$68.92 - $91.14 $141,837 - $187,566
2,058 New
2,058 $182,000
Q1 2020

Apr 23, 2020

SELL
$63.37 - $90.13 $299,930 - $426,585
-4,733 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$72.49 - $85.45 $1.14 Million - $1.34 Million
-15,722 Reduced 76.86%
4,733 $402,000
Q3 2019

Oct 29, 2019

BUY
$65.59 - $78.07 $525,507 - $625,496
8,012 Added 64.39%
20,455 $1.56 Million
Q1 2019

Apr 29, 2019

SELL
$63.27 - $82.0 $392,716 - $508,974
-6,207 Reduced 33.28%
12,443 $991,000
Q4 2018

Jan 29, 2019

SELL
$61.13 - $74.67 $899,589 - $1.1 Million
-14,716 Reduced 44.1%
18,650 $1.24 Million
Q3 2018

Oct 23, 2018

BUY
$61.25 - $71.13 $1.89 Million - $2.2 Million
30,866 Added 1234.64%
33,366 $2.35 Million
Q2 2018

Jul 17, 2018

SELL
$61.14 - $69.55 $3.81 Million - $4.33 Million
-62,315 Reduced 96.14%
2,500 $155,000
Q1 2018

May 02, 2018

SELL
$65.05 - $74.82 $2.05 Million - $2.36 Million
-31,555 Reduced 32.74%
64,815 $4.29 Million
Q4 2017

Jan 26, 2018

BUY
$64.87 - $70.59 $3.31 Million - $3.6 Million
50,980 Added 112.32%
96,370 $6.54 Million
Q3 2017

Nov 06, 2017

BUY
$58.57 - $66.17 $2.66 Million - $3 Million
45,390
45,390 $2.91 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.8B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.